IL-7 sensitizes human pre-B cells but not pro-B cells to Fas/APO-1 (CD95)-mediated apoptosis

Clinical and Experimental Immunology

Volumn 110, Issue 2, 1997, Pages 329-335

  Levy, Y ^a,b   Benlagha, K ^b   Buzyn, A ^c   Colombel, M ^a   Brouet, J C ^b   Lassoued, K ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b SAINT LOUIS HOSPITAL   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

CD95; IL 7; Pre B cells; Pro B cells

Indexed keywords

FAS ANTIGEN; INTERLEUKIN 7;

ACUTE LYMPHOBLASTIC LEUKEMIA; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL PROLIFERATION; HUMAN; HUMAN CELL; LYMPHOPOIESIS; PRIORITY JOURNAL; STEM CELL;

EID: 0030732050     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.1997.tb08336.x     Document Type: Article

References (46)

1. Cooper MD. B Lymphocytes: normal development and function. N Engl J Med 1987; 317:1452-6.
2. Kincade PW, Lee G, Pietrangeli CE, Hayashi SI, Gimble JM. Cells and molecules that regulate B lymphopoiesis in bone marrow. Annu Rev Immunol 1989; 7:111-43.
3. Uckun FM. Regulation of human B-cell ontogeny. Blood 1990; 76:1908-23.
4. Rolink A, Kudo A, Karasuyama H, Kikuchi Y, Melchers F. Long-term proliferating early pre B cell lines and clones with the potential to develop to surface Ig-positive, mitogen reactive B cells in vitro and in vivo. EMBO 1991; 10:327-36.
5. Nadler LM, Anderson KC, Marti G, Bates M, Park E, Daley JF, Schlossman SF. B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes. J Immunol 1983; 131:244-50.
6. Lassoued K, Nunez CA, Billips L, Kubagawa H, Monteiro RC, LeBien TW, Cooper MD. Expression of surrogate light chain receptors is restricted to a late stage in pre-B cell differentiation. Cell 1993; 73:73-86.
7. Nagata S, Golstein P. The fas death factor. Science 1995; 267:1449-56.
8. Krammer PH, Dhein J, Walczak H et al. The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 1994; 142:175-91.
9. Lagresle C, Bella C, Daniel PT, Krammer PH, Defrance T. Regulation of germinal center B cell differentiation. J Immunol 1995; 154:5746-56.
10. Trauth BC, Klas C, Peters AM, Matzku S, Moler P, Falk W, Debatin KM, Krammer PH. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science (Wash. DC) 1989; 245:301-5.
11. Yonehara S, Ishii A, Yonehara M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J Exp Med 1989; 169:1747-56.
12. Daniel PT, Krammer PH. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J Immunol 1994; 152:5624.
13. Korsmeyer SJ, Arnold A, Bakhshi A et al. Immunoglobulin gene rearrangement and cell surface antigen expression in acute lymphoblastic leukemias of T cell and B cell precursor origins. J Clin Invest 1983; 71:301-13.
14. Stong RC, Korsmeyer SJ, Parkin JL, Arthur DC, Kersey JH. Human acute leukemia cell line with the t(4;11) chromosomal rearrangement exhibits B lineage and monocytic characteristics. Blood 1985; 65:21-31.
15. Findley HW, Cooper MD, Kim JH, Alvarado C, Ragab AH. Two new acute lymphoblastic leukemia cell lines with early B-cell phenotypes. Blood 1982; 60:1305-9.
16. Lassoued K, Illges H, Benlagha K, Cooper MD. Fate of the surrogate light chains in B lineage cells. J Exp Med 1996; 183:421-9.
17. Nakamura T, Kubagawa H, Cooper MD. Heterogeneity of immunoglobulin-associated molecules on human B cells identified by monoclonal antibodies. Proc Natl Acad Sci USA 1992; 89:8522-6.
18. Ewert DL, Munchus MS, Chen CH, Cooper MD. Analysis of structural properties and cellular distribution of avian la antigen by using monoclonal antibody to monomorphic determinants. J Immunol 1984; 132:2524-30.
19. Levy Y, Brouet JC. Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the Bcl-2 protein. J Clin Invest 1994; 93:424-8.
20. Levy Y, Labaume S, Colombel M, Brouet JC. Retinoic acid modulates the in vivo and in vitro growth of 116 autocrine human myeloma cell lines via induction of apoptosis. Clin Exp Immunol 1996; 104:167.
21. Chen J, Ma A, Young F, Alt FW. IL-2 receptor α chain expression during early B lymphocyte differentiation. Int Immunol 1994; 6:1265-8.
22. Wörmann B, Gesner TG, Mufson RA, LeBien TW. Proliferative effect of interleukin-3 on normal and leukemic human B cell precursors. Leukemia 1989; 3:399-403.
23. Pandrau D, Saeland S, Duvert V, Durand I, Manel AM, Zabot MT, Philippe N, Banchereau J. Interleukin 4 inhibits in vitro proliferation of leukemic and normal human B cell precursors. J Clin Invest 1992; 90:1697-706.
24. McGinnes K, Quesniaux V, Hitzler J, Paige CJ. Human B-lymphopoiesis is supported by bone marrow-derived stromal cells. Exp Hematol 1991; 19:294-303.
25. Wolf ML, Buckley JA, Goldfarb A, Law CL, LeBien TW. Development of a bone marrow culture for maintenance and growth of normal human B cell precursors. J Immunol 1991; 147:3324-30.
26. Moreau I, Duvert V, Bancherau J, Saeland S. Culture of human fetal B-cell precursors on bone marrow stroma maintains highly proliferative CD20 dim cells. Blood 1993; 81:1170-8.
27. Saeland S, Duvert V, Pandrau D et at. Interleukin-7 induces the proliferation of normal human B-cell precursors. Blood 1991; 78:2229-38.
28. Grabstein KH, Waldschmidt TJ, Finkelman FD, Hess BW, Alpert AR, Boiani NE, Namen AE, Morrissey PJ. Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med 1993; 178:257-64.
29. Peschon JJ, Morrissey PJ, Grabstein KH et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994; 180:1955-60.
30. Freeden-Jeffry UV, Vieira P, Lucian LA, McNeil T, Burdach SEG, Murray R. Lymphopenia in interleukin (IL)-7 gene deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995; 181:1519-26.
31. Uckun FM, Dibirdik I, Smith R et al. Interleukin 7 receptor ligation stimulates tyrosine phosphorylation, inositol phospholipid turnover, and clonal proliferation of human B-cell precursors. Proc Natl Acad Sci USA 1991; 88:3589-93.
32. Pribyl JAR, LeBien TW. Interleukin 7 independent development of human B cells. Proc Natl Acad Sci USA 1996; 93:10348-53.
33. Billips LG, Nunez CA, Bertrand IIIFE, Stankovic AK, Gartland GL, Burrows PD, Cooper MD. Immunoglobulin recombinase gene activity is modulated reciprocally by interleukin 7 and CD19 in B cell progenitors. J Exp Med 1995; 182:973-82.
34. Griffiths SD, Goodhead DT, Marsden SJ, Wright EG, Krajewski S, Reed JC, Korsmeyer SJ, Greaves M. Interleukin 7-dependent B lymphocyte precursor cells are ultrasensitive to apoptosis. J Exp Med 1994; 179:1789-96.
35. Melchers F, Karasuyama H, Haasner D, Bauer S, Kudo A, Sakaguchi N, Jameson B, Rolink A. The surrogate light chain in B-cell development. Immunol Today 1993; 14:60-78.
36. Kitamura D, Kudo A, Schaal S, Müller W, Melchers F, Rajewsky K. A critical role of λ5 protein in B cell development. Cell 1992; 69:823-31.
37. Oltvai ZN, Korsmeyer SJ. Check points of dueling dimers oil death wishes. Cell 1994; 79:189-92.
38. Daniel FT, Krammer PH. Activation induces sensitivity toward APO-1 (CD95)-mediated apoptosis in human B cells. J Immunol 1994; 152:5624-32.
39. Onel KB, Tucek-Szabo CL, Ashany D, Lacy E, Nikolic-Zugic J, Elkon KB. Expression and function of the murine CD95/FasR/APO-1 receptor in relation to B cell ontogeny. Eur J Immunol 1995; 25:2940-7.
40. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992; 356:314-7.
41. Reap EA, Sobel ES, Cohen PL, Esisenberg RA. Conventional B cells, not B-1 cells, are responsible for producing autoantibodies in lpr mice. J Exp Med 1993; 177:69-78.
42. Mandik L, Nguyen K-AT, Erikson J. Fas receptor expression on B-lineage cells. Eur J Immunol 1995; 25:3148-54.
43. McDonnell TJ, Deane N, Platt FM, Nunez G, Jaeger U, Mck-earn JP, Korsmeyer SJ. Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell 1989; 57:79-88.
44. Veis DJ, Sorenson CM, Shutter JR, Korsmeyer SJ. Bcl-2-deficient mice demonstrate fulminant lymphoid apoptosis, polycystic kidneys, and hypopigmented hair. Cell 1993; 75:229-40.
45. Young F, Mizoguchi E, Bhan AK, Alt FW. Constitutive Bcl2 expression during immunoglobulin heavy chain-promoted B cell differentiation expands novel precursor B cells. Immunity 1997; 6:23-27.
46. Carsetti R, Kohler G, Lamers MC. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 1995; 181:2129-40.